Pulmonary Hypertension (PH) is a relatively rare disease, and certainly not a household term that many people are familiar with. And yet, the research community is highly active in pursuing PH research and developing novel treatments for the disease. Pulmonary Hypertension News is a digital news publication dedicated to offering comprehensive daily news coverage of the science, medicine, and human interest stories surrounding the effects of the disease, as well as the effort underway to treat and eventually cure it.

The editors at Pulmonary Hypertension News are committed to sourcing and covering PH stories on a daily basis, creating the first and only 24-hour news cycle for the disease. Between groundbreaking research in the lab, critical findings in clinical trials for novel PH therapies, game-changing funding announcements for furthering PH R&D, and heartwarming human interest stories that highlight the powerful Pulmonary Hypertension support community, there is enough news each day to keep PH patients, their families, and other researchers informed on the progress being made in treating and curing the disease.

Pulmonary Hypertension News features a talented, dynamic editorial staff with a wide range of backgrounds into science and health. Below is the current of our professional writers and editors who contribute to the news cycle each day:

Pulmonary Hypertension News’ Editorial Staff:

Chris Comish — Publisher: Publisher Chris Comish is actively engaged on a daily basis in supporting the editorial staff and works to source fresh, informative news stories that can make a difference in the lives of those in search of reliable news and content on the web.

Grace Frank — Editor-in-Chief: Grace Frank worked as a copy editor, city editor, reporter and news designer for leading American newspapers, including The New York Times and The International Herald Tribune, for many years. She has won numerous journalism awards, and was nominated for a Pulitzer Prize for an investigative series into eye surgeries wrongly conducted outside a clinical trial.

Patrícia Silva, PhD — Senior Managing News Editor: Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

Margarida Azevedo — Managing News Editor: Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

Ines Martins, PhD — Managing News Editor: Inês holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

Ozge Ozkaya, PhD — Managing Resource Pages Editor: Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.

Samantha Spiesman — Social Media Content Director:

Isaura Santos — Social Media Promotion Director: Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

Carol Jertson — Copy Editor: Carol Jertson, a New Jersey native who lives in South Florida, is an award-winning journalist who has worked as a reporter, copy editor, and assistant city editor for small and big-city daily newspapers, including the Miami Herald and the Atlantic City Press, where she wrote stories about the mob when organized crime owned the unions that ran the casinos. At the Miami Herald, her staff of reporters covered local beats and the intricacies of state government. Most recently, she worked for Newsmax, an online site that reported political, national and global news.

Charles Moore — Technology Editor: Charles Moore has a long-proven track record in both print and digital journalism, touching on a wide range of subjects, from biotech and healthcare to politics and technology. He contributes substantial feature articles research and development for the news site, particularly pertaining to technology.

Magdalena Kegel, PhD — Senior Research Columnist: Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

Patrícia Inacio, PhD — Senior Research Columnist: Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

Teresa Pais, PhD — Research Columnist: Teresa F. Pais holds her PhD in Biomedical Sciences from University of Porto. She has worked in innate immune responses in the context of both infection and neurodegeneration. Currently, she is a researcher at Instituto de Medicina Molecular where she investigates inflammatory processes in the brain.

Carolina Henriques – Daily Columnist: Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

Andreia Peixoto — Social Media Manager: Andreia has a degree in New Communication Technologies and experience in social media, design and tech. She is eager to find new ways to communicate and explore her curiosity about science and technology.

Marta Ribeiro — Social Media Manager: Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

All writers can be contacted through Pulmonary Hypertension News’ contact page.

DISCLAIMER: Pulmonary Hypertension News is a science and health publishing website that occasionally writes about clinical trials taking place in the PH research community. The information provided on this site is designed to help educate patients on clinical trials that may be of interest to them, based on the topic of the story, and to help patients contact the centers conducting the research. PH News is neither promoting research nor involved in conducting any clinical trials. Some study summaries have been edited for clarity purposes to make them easier to understand.

Note: Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Leave a Comment

Your email address will not be published. Required fields are marked *